More Business Wire
View Older Stories View Newer Stories-
Imperial announces second quarter 2026 financial and operating results
-
Moog Inc. Achieves Record Third Quarter 2026 Results Through Operational Excellence and Raises Full-Year Guidance
-
Imperial declares third quarter 2026 dividend
-
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 2026
-
Real-Money Odds Have Entered the News Cycle. Their Fine Print Has Not
-
Dominion Energy Announces Second-Quarter 2026 Results
-
Balance Theory Raises $19M to Reinvent How Enterprises Manage Cybersecurity Investments
-
EagleRock to Report Second Quarter 2026 Results on August 10, 2026
-
CORSAIR Deepens Strategic Relationship with Bitfocus, Extending Elgato’s Reach into Professional Broadcast and Live Production
-
Phillips 66 announces additional share repurchase authorization
-
Precision BioSciences to Report Second Quarter 2026 Financial Results on August 6, 2026
-
Fresenius Announces FDA and EMA Acceptance for Review of Vedolizumab Biosimilar Candidate
-
Atlas Energy Solutions Expands AI-Enabled Digital Transformation of Oilfield Logistics with Kodiak-Powered Driverless Trucks
-
AutoNation Reports Second Quarter 2026 Results
-
Colgate Announces 2nd Quarter 2026 Results
-
Church & Dwight Delivers Strong Second Quarter Results
-
Vista Gold Highlights Mt Todd Progress and Announces Participation in Australia’s Diggers & Dealers Mining Forum
-
Cameco Reports Second Quarter Results: Year-to-Date Performance on Track; Production Outlook Unchanged; Strategically Positioned Across the Nuclear Fuel Cycle; Significant Support for Nuclear Energy R
-
Newell Brands Announces Second Quarter 2026 Results
-
Eaton Reports Record Second Quarter 2026 Results, with Strong Organic Growth, Accelerating Orders and Backlog, and Raises Organic Growth Guidance
-
ExxonMobil Announces Second-Quarter 2026 Results
-
Algonquin Power & Utilities Corp. Announces Date for Second Quarter 2026 Financial Results and Conference Call
-
NGL Energy Partners LP Announces Availability of its 2025 Schedule K-3s
-
Cameco Announces Westinghouse’s Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering
-
Chevron Reports Second Quarter 2026 Results
-
AngloGold Ashanti Q2 30 June 2026 Earnings Release and Dividend Declaration
-
Carter’s, Inc. Reports Second Quarter Fiscal 2026 Results
-
WisdomTree Announces Second Quarter 2026 Results
-
Protolabs Reports Financial Results for the Second Quarter of 2026
-
Pursuit Completes Strategic Divestiture of Flyover Business, Strengthening Focus on Growth in Iconic Destinations
-
Westinghouse Confidentially Submits Draft Registration Statement for Proposed Initial Public Offering
-
Finite State Joins DEF CON 2026 with AI Offensive Security and RAISE Act Sessions and a Hands-On Manufacturing Incident Response Challenge
-
Linde Reports Second-Quarter 2026 Results
-
Orano Med Provides Half-Year Progress Report and Business Outlook
-
Linde to Invest $1 Billion to Support Major U.S. Semiconductor Facility Expansion
-
Intropy Announces $11 Million in Funding to Build the AI-Native Operating System for the Spare Parts Supply Chain
-
Daiichi Sankyo Reports First Quarter Fiscal Year 2026 Financial Results
-
Oasis Welcomes Significant SHiDAX Decision Affirming the Need for Substantive Fairness in Japanese M&A
-
KKR and Mirastar Complete Acquisition of Portfolio of Four Prime UK Logistics Assets from PLP
-
KBRA Releases Research – KBRA-Rated European RMBS Exposure to Wildfires in Spain
-
RHI Magnesita 2026 Half Year Results: Consistent Self-help Delivery and Strong Steel Business Performance Delivers 42% Adj. EBITA Growth on Constant Currency Basis
-
CoStar Data Shows London Dominates UK Office Development as Regional Pipeline Hits 20-Year Low
-
Mitsubishi Electric Announces Consolidated Financial Results for the First Quarter of Fiscal 2027
-
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy
-
Orano: 2026 Half-Year Results in Line With Annual Outlook Despite Circumstantial Production Stoppages
-
Notice Concerning the Recording of Finance Income
-
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate
-
Renesas to Phase Out Production at Takasaki Factory; Maintain and Strengthen R&D Functions
-
Renesas Reports Financial Results for the Second Quarter Ended June 30, 2026
-
Renesas Announces Consolidated Forecasts
